Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: A cross-sectional study

Breast Cancer Research

Volumn 9, Issue 1, 2007, Pages

  Tamimi, Rulla M ^a,b   Cox, David G ^a,b   Kraft, Peter ^b   Pollak, Michael N ^c   Haiman, Christopher A ^d   Cheng, Iona ^e   Freedman, Matthew L ^f   Hankinson, Susan E ^a,b   Hunter, David J ^a,b,g   Colditz, Graham A ^b,g  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; IGFBP1 PROTEIN, HUMAN; IGFBP3 PROTEIN, HUMAN; SOMATOMEDIN BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; CANCER SCREENING; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSTMENOPAUSE; PREMENOPAUSE; PROBABILITY; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE; BREAST TUMOR; GENETICS; MIDDLE AGED; PATHOLOGY; STATISTICS;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MAMMOGRAPHY; MIDDLE AGED; VARIATION (GENETICS);

EID: 34248137067     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1655     Document Type: Article

References (62)

1. Byrne C Schairer C Wolfe J Parekh N Salane M Brinton LA Hoover R Haile R Mammographic features and breast cancer risk: Effects with time, age, and menopause status J Natl Cancer Inst 1995, 87:1622-1629. 10.1093/jnci/ 87.21.1622 7563205
2. Boyd NF Byng JW Jong RA Fishell EK Little LE Miller AB Lockwood GA Tritchler DL Yaffe MJ Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study J Natl Cancer Inst 1995, 87:670-675. 10.1093/jnci/ 87.9.670 7752271
3. Clemons M Goss P Estrogen and the risk of breast cancer N Engl J Med 2001, 344:276-285. 10.1056/NEJM200101253440407 11172156
4. Tamimi RM Hankinson SE Colditz GA Byrne C Endogenous sex hormone levels and mammographic density among postmenopausal women Cancer Epidemiol Biomarkers Prev 2005, 14:2641-2647. 10.1158/1055-9965.EPI-05-0558 16284390
5. Kerlikowske K Shepherd J Creasman J Tice JA Ziv E Cummings SR Are breast density and bone mineral density independent risk factors for breast cancer? J Natl Cancer Inst 2005, 97:368-374. 15741573
6. Ziv E Tice J Smith-Bindman R Shepherd J Cummings S Kerlikowske K Mammographic density and estrogen receptor status of breast cancer Cancer Epidemiol Biomarkers Prev 2004, 13:2090-2095. 15598766
7. Laban C Bustin SA Jenkins PJ The GH-IGF-I axis and breast cancer Trends Endocrinol Metab 2003, 14:28-34. 10.1016/S1043-2760(02)00003-6 12475609
8. Alowami S Troup S Al-Haddad S Kirkpatrick I Watson PH Mammographic density is related to stroma and stromal proteoglycan expression Breast Cancer Res 2003, 5:R129-R135. 314426 12927043 10.1186/bcr622
9. Guo YP Martin LJ Hanna W Banerjee D Miller N Fishell E Khokha R Boyd NF Growth factors and stromal matrix proteins associated with mammographic densities Cancer Epidemiol Biomarkers Prev 2001, 10:243-248. 11303594
10. Schernhammer ES Holly JM Pollak MN Hankinson SE Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk Cancer Epidemiol Biomarkers Prev 2005, 14:699-704. 10.1158/ 1055-9965.EPI-04-0561 15767352
11. Fletcher O Gibson L Johnson N Altmann DR Holly JM Ashworth A Peto J Silva Idos S Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: A systematic review Cancer Epidemiol Biomarkers Prev 2005, 14:2-19. 15668470
12. Rinaldi S Toniolo P Muti P Lundin E Zeleniuch-Jacquotte A Arslan A Micheli A Lenner P Dossus L Krogh V IGF-I, IGFBP-3 and breast cancer in young women: A pooled re-analysis of three prospective studies Eur J Cancer Prev 2005, 14:493-496. 10.1097/00008469-200512000-00001 16284492
13. Rinaldi S Peeters PH Berrino F Dossus L Biessy C Olsen A Tjonneland A Overvad K Clavel-Chapelon F Boutron-Ruault MC IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC) Endocr Relat Cancer 2006, 13:593-605. 10.1677/ erc.1.01150 16728585
14. Schernhammer ES Holly JM Hunter DJ Pollak MN Hankinson SE Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II Endocr Relat Cancer 2006, 13:583-592. 10.1677/erc.1.01149 16728584
15. Boyd NF Stone J Martin LJ Jong R Fishell E Yaffe M Hammond G Minkin S The association of breast mitogens with mammographic densities Br J Cancer 2002, 87:876-882. 10.1038/sj.bjc.6600537 12373602
16. Byrne C Colditz GA Willett WC Speizer FE Pollak M Hankinson SE Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density Cancer Res 2000, 60:3744-3748. 10919644
17. Maskarinec G Williams AE Kaaks R A cross-sectional investigation of breast density and insulin-like growth factor I Int J Cancer 2003, 107:991-996. 10.1002/ijc.11505 14601060
18. Boyd NF Dite GS Stone J Gunasekara A English DR McCredie MR Giles GG Tritchler D Chiarelli A Yaffe MJ Hopper JL Heritability of mammographic density, a risk factor for breast cancer N Engl J Med 2002, 347:886-894. 10.1056/NEJMoa013390 12239257
19. Pankow JS Vachon CM Kuni CC King RA Arnett DK Grabrick DM Rich SS Anderson VE Sellers TA Genetic analysis of mammographic breast density in adult women: Evidence of a gene effect J Natl Cancer Inst 1997, 89:549-556. 10.1093/jnci/89.8.549 9106643
20. Haiman CA Hankinson SE De Vivo I Guillemette C Ishibe N Hunter DJ Byrne C Polymorphisms in steroid hormone pathway genes and mammographic density Breast Cancer Res Treat 2003, 77:27-36. 10.1023/A:1021112121782 12602902
21. Haiman CA Bernstein L Berg D Ingles SA Salane M Ursin G Genetic determinants of mammographic density Breast Cancer Res 2002, 4:R5. 111030 12052257 10.1186/bcr434
22. Maskarinec G Lurie G Williams AE Le Marchand L An investigation of mammographic density and gene variants in healthy women Int J Cancer 2004, 112:683-688. 10.1002/ijc.20448 15382051
23. Warren R Skinner J Sala E Denton E Dowsett M Folkerd E Healey CS Dunning A Doody D Ponder B Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women Cancer Epidemiol Biomarkers Prev 2006, 15:1502-1508. 10.1158/1055-9965.EPI-05-0828 16896040
24. Lord SJ Mack WJ Van Den Berg D Pike MC Ingles SA Haiman CA Wang W Parisky YR Hodis HN Ursin G Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: Results from a pilot study Breast Cancer Res 2005, 7:R336-R344. 1143576 15987428 10.1186/bcr999
25. Hong CC Thompson HJ Jiang C Hammond GL Tritchler D Yaffe M Boyd NF Association between the T27C polymorphism in the cytochrome P450 c17α (CYP17) gene and risk factors for breast cancer Breast Cancer Res Treat 2004, 88:217-230. 10.1007/s10549-004-0780-7 15609124
26. Hong CC Thompson HJ Jiang C Hammond GL Tritchler D Yaffe M Boyd NF Val158Met polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer Cancer Epidemiol Biomarkers Prev 2003, 12:838-847. 14504192
27. dos Santos Silva I Johnson N De Stavola B Torres-Mejia G Fletcher O Allen DS Allen NE Key TJ Fentiman IS Holly JM Peto J The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women Cancer Epidemiol Biomarkers Prev 2006, 15:449-455. 10.1158/1055-9965.EPI-05-0555 16537700
28. Lai JH Vesprini D Zhang W Yaffe MJ Pollak M Narod SA A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density Cancer Epidemiol Biomarkers Prev 2004, 13:573-582. 15066922
29. Colditz GA Hankinson SE The Nurses' Health Study: Lifestyle and health among women Nat Rev Cancer 2005, 5:388-396. 10.1038/nrc1608 15864280
30. Hankinson SE Willett WC Manson JE Colditz GA Hunter DJ Spiegelman D Barbieri RL Speizer FE Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women J Natl Cancer Inst 1998, 90:1292-1299. 10.1093/jnci/90.17.1292 9731736
31. Missmer SA Eliassen AH Barbieri RL Hankinson SE Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women J Natl Cancer Inst 2004, 96:1856-1865. 15601642
32. Byng JW Boyd NF Little L Lockwood G Fishell E Jong RA Yaffe MJ Symmetry of projection in the quantitative analysis of mammographic images Eur J Cancer Prev 1996, 5:319-327. 10.1097/00008469-199610000-00003 8972250
33. Byrne C Mammographic density and breast cancer risk: The evolution of assessment techniques and implications for understanding breast cancer Semin Breast Dis 1999, 2:301-314.
34. Kolonel LN Henderson BE Hankin JH Nomura AM Wilkens LR Pike MC Stram DO Monroe KR Earle ME Nagamine FS A multiethnic cohort in Hawaii and Los Angeles: Baseline characteristics Am J Epidemiol 2000, 151:346-357. 10695593
35. Hunter DJ Riboli E Haiman CA Albanes D Altshuler D Chanock SJ Haynes RB Henderson BE Kaaks R Stram DO A candidate gene approach to searching for low-penetrance breast and prostate cancer genes Nat Rev Cancer 2005, 5:977-985. 10.1038/nrc1754 16341085
36. The Multiethnic Cohort genetic study http://www.uscnorris.com/ MECGenetics/
37. Cheng I Stram DO Penney KL Pike M Le Marchand L Kolonel LN Hirschhorn J Altshuler D Henderson BE Freedman ML Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort J Natl Cancer Inst 2006, 98:123-134. 16418515
38. Cheng I Penney KL Stram DO Le Marchand L Giorgi E Haiman CA Kolonel LN Pike MC Hirschhorn JN Henderson BE Freedman ML Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: The Multiethnic Cohort Cancer Epidemiol Biomarkers Prev 2006, 15:1993-1997. 10.1158/1055-9965.EPI-06-0361 17035411
39. Lewontin RC The interaction of selection and linkage. II. Optimum models Genetics 1964, 50:757-782. 1210693 14221879
40. Gabriel SB Schaffner SF Nguyen H Moore JM Roy J Blumenstiel B Higgins J DeFelice M Lochner A Faggart M The structure of haplotype blocks in the human genome Science 2002, 296:2225-2229. 10.1126/science.1069424 12029063
41. Haplotype tagging SNP (htSNP) selection in the Multiethnic Cohort Study http://www-rcf.usc.edu/∼stram/tagSNPs.html
42. Stram DO Haiman CA Hirschhorn JN Altshuler D Kolonel LN Henderson BE Pike MC Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study Hum Hered 2003, 55:27-36. 10.1159/000071807 12890923
43. NCI Cohort Consortium - Taqman Genotyping Call Key http://www.uscnorris.com/mecgenetics/CohortGCKView.aspx
44. Kraft P Cox DG Paynter RA Hunter D De Vivo I Accounting for haplotype uncertainty in matched association studies: A comparison of simple and flexible techniques Genet Epidemiol 2005, 28:261-272. 10.1002/gepi.20061 15637718
45. Zaykin DV Westfall PH Young SS Karnoub MA Wagner MJ Ehm MG Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals Hum Hered 2002, 53:79-91. 10.1159/000057986 12037407
46. Hirschhorn JN Daly MJ Genome-wide association studies for common diseases and complex traits Nat Rev Genet 2005, 6:95-108. 10.1038/ nrg1521 15716906
47. Westfall PH Zaykin DV Young SS Multiple tests for genetic effects in association studies Methods Mol Biol 2002, 184:143-168. 11889711
48. Li CI Malone KE Daling JR Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older Cancer Epidemiol Biomarkers Prev 2002, 11:601-607. 12101106
49. Anderson WF Chu KC Chang S Sherman ME Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma Cancer Epidemiol Biomarkers Prev 2004, 13:1128-1135. 15247123
50. McTiernan A Martin CF Peck JD Aragaki AK Chlebowski RT Pisano ED Wang CY Brunner RL Johnson KC Manson JE Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative Randomized Trial J Natl Cancer Inst 2005, 97:1366-1376. 16174858
51. Greendale GA Reboussin BA Slone S Wasilauskas C Pike MC Ursin G Postmenopausal hormone therapy and change in mammographic density J Natl Cancer Inst 2003, 95:30-37. 12509398
52. Brisson J Brisson B Cote G Maunsell E Berube S Robert J Tamoxifen and mammographic breast densities Cancer Epidemiol Biomarkers Prev 2000, 9:911-915. 11008908
53. Diorio C Pollak M Byrne C Masse B Hebert-Croteau N Yaffe M Cote G Berube S Morin C Brisson J Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density Cancer Epidemiol Biomarkers Prev 2005, 14:1065-1073. 10.1158/1055-9965.EPI-04-0706 15894654
54. Kaaks R Nutrition, insulin, IGF-1 metabolism and cancer risk: A summary of epidemiological evidence Novartis Found Symp 2004, 262:247-260. 15562834
55. Giovannucci E Insulin, insulin-like growth factors and colon cancer: A review of the evidence J Nutr 2001, 131:(11 Suppl)3109S-3120S. 11694656
56. Morimoto LM Newcomb PA White E Bigler J Potter JD Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: Personal and lifestyle factors (United States) Cancer Causes Control 2005, 16:917-927. 10.1007/s10552-005-2702-3 16132801
57. Heald A Kaushal K Anderson S Redpath M Durrington PN Selby PL Gibson MJ Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk Gynecol Endocrinol 2005, 20:176-182. 16019358
58. Holmes MD Pollak MN Hankinson SE Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations Cancer Epidemiol Biomarkers Prev 2002, 11:862-867. 12223430
59. Al-Zahrani A Sandhu MS Luben RN Thompson D Baynes C Pooley KA Luccarini C Munday H Perkins B Smith P IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer Hum Mol Genet 2006, 15:1-10. 10.1093/hmg/ddi398 16306136
60. Schernhammer ES Hankinson SE Hunter DJ Blouin MJ Pollak MN Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk Int J Cancer 2003, 107:60-64. 10.1002/ijc.11358 12925957
61. Deal C Ma J Wilkin F Paquette J Rozen F Ge B Hudson T Stampfer M Pollak M Novel promoter polymorphism in insulin-like growth factor-binding protein-3: Correlation with serum levels and interaction with known regulators J Clin Endocrinol Metab 2001, 86:1274-1280. 10.1210/ jc.86.3.1274 11238520
62. Setiawan VW Cheng I Stram DO Penney KL Le Marchand L Altshuler D Kolonel LN Hirschhorn J Henderson BE Freedman ML IGF-I genetic variation and breast cancer: The multiethnic cohort Cancer Epidemiol Biomarkers Prev 2006, 15:172-174. 10.1158/1055-9965.EPI-05-0625 16434607